Abstract
Congenital infections are those that are acquired transplacentally by the fetus from an infected mother. They constitute a major public health burden, affecting millions of infants and children worldwide. Despite significant advances in medical diagnostics, the majority of newborns with congenital infections are not recognized, since many of these infections may not cause clinically - apparent disease in the newborn period. Nonetheless, these infections - whether they are apparent or silent - have the potential to adversely impact the neurodevelopmental outcomes of these vulnerable children.
Keywords: Cytomegalovirus, CMV, congenital infection, HIV, rubella, syphilis, toxoplasmosis, congenital syphilis, herpes simplex virus (HSV), Lyme disease, valganciclovir, Screening, newborns, Obstetricians
Infectious Disorders - Drug Targets
Title: Overview of Congenital Infections: The Prominence of Cytomegalovirus
Volume: 11 Issue: 5
Author(s): Joseph B. Cantey and Pablo J. Sanchez
Affiliation:
Keywords: Cytomegalovirus, CMV, congenital infection, HIV, rubella, syphilis, toxoplasmosis, congenital syphilis, herpes simplex virus (HSV), Lyme disease, valganciclovir, Screening, newborns, Obstetricians
Abstract: Congenital infections are those that are acquired transplacentally by the fetus from an infected mother. They constitute a major public health burden, affecting millions of infants and children worldwide. Despite significant advances in medical diagnostics, the majority of newborns with congenital infections are not recognized, since many of these infections may not cause clinically - apparent disease in the newborn period. Nonetheless, these infections - whether they are apparent or silent - have the potential to adversely impact the neurodevelopmental outcomes of these vulnerable children.
Export Options
About this article
Cite this article as:
B. Cantey Joseph and J. Sanchez Pablo, Overview of Congenital Infections: The Prominence of Cytomegalovirus, Infectious Disorders - Drug Targets 2011; 11 (5) . https://dx.doi.org/10.2174/187152611797636677
DOI https://dx.doi.org/10.2174/187152611797636677 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Porphyromonas gingivalis Mediated Periodontal Disease and Atherosclerosis:Disparate Diseases with Commonalities in Pathogenesis Through TLRs
Current Pharmaceutical Design p38 MAPK: A Potential Target of Chronic Pain
Current Medicinal Chemistry Chemical Consequences of Radioactive Decay and their Biological Implications
Current Radiopharmaceuticals The Extracellular Bacterial HtrA Proteins as Potential Therapeutic Targets and Vaccine Candidates
Current Medicinal Chemistry Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
CNS & Neurological Disorders - Drug Targets Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?
Current Pediatric Reviews microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
MicroRNA Targeting Protozoan Parasite Metabolism: Glycolytic Enzymes in the Therapeutic Crosshairs
Current Medicinal Chemistry Oestradiol Signalling in the Hippocampus
Current Neuropharmacology Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Current Pharmaceutical Design Current Challenges and Updates on the Therapy of Fungal Infections
Current Topics in Medicinal Chemistry Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimers Disease: A Review of Recent Clinical Studies
Current Alzheimer Research Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
Current Pharmaceutical Design How to Get from Here to There: Macrophage Recruitment in Alzheimers Disease
Current Alzheimer Research Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Current Radiopharmaceuticals Defensins: Key Molecules in Ocular Surface Protection
Current Immunology Reviews (Discontinued) Inorganic-organic Nanomaterials for Therapeutics and Molecular Imaging Applications
Nanoscience & Nanotechnology-Asia Murine Skin-resident γδT Cells Impair the Immune Response to HSV in Skin
Infectious Disorders - Drug Targets Host-Cell Survival and Death During Chlamydia Infection
Current Immunology Reviews (Discontinued) The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Current Pharmaceutical Design